Daniella I. Galdermans
Antwerpen, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Efficacy and safety of capecitabine-temozolomide (CAPTEM) regimen in patients with neuroendocrine neoplasms - experience from NETwerk, a Belgian ENETS Center of Excellence.
Journal: Acta gastro-enterologica Belgica
Published: June 12, 2025
Real-World Treatment Patterns, Epidermal Growth Factor Receptor (EGFR) Testing and Outcomes in EGFR-Mutated Advanced Non-small Cell Lung Cancer Patients in Belgium: Results from the REVEAL Study.
Journal: Drugs - real world outcomes
Published: March 06, 2021
Coping Strategy Influences Quality of Life in Patients With Advanced Lung Cancer by Mediating Mood.
Journal: Clinical lung cancer
Published: April 27, 2020
Should oral anticoagulation be discontinued after 3 months in the setting of a first high-risk pulmonary embolism secondary to a major transient/reversible risk factor?
Journal: The European respiratory journal
Published: October 15, 2019
The genomic landscape of nonsmall cell lung carcinoma in never smokers.
Journal: International journal of cancer
Published: March 28, 2019
A Multicenter Study to Assess EGFR Mutational Status in Plasma: Focus on an Optimized Workflow for Liquid Biopsy in a Clinical Setting.
Journal: Cancers
Published: July 16, 2018
Does nivolumab for progressed metastatic lung cancer fulfill its promises? An efficacy and safety analysis in 20 general hospitals.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: September 29, 2017
Phase II study of afatinib, an irreversible ErbB family blocker, in demographically and genotypically defined lung adenocarcinoma.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 28, 2014
Use of an Amplatzer Device for Endoscopic Closure of a Large Bronchopleural Fistula following Lobectomy for a Stage I Squamous Cell Carcinoma.
Journal: Case reports in oncology
Published: December 19, 2013
Survival outcomes in patients with advanced non-small cell lung cancer treated with erlotinib: expanded access programme data from Belgium (the TRUST study).
Journal: European journal of cancer care
Published: September 15, 2013
Geriatric screening results and the association with severe treatment toxicity after the first cycle of (radio)chemotherapy.
Journal: Journal of geriatric oncology
Published: May 13, 2013
Long-term disease control of a non-operable neuroendocrine tumor of the lung with lanreotide: a case study.
Journal: Case reports in oncology
Published: January 24, 2013
Last Updated: 09/26/2026